Lobbying

National Cardiovascular Partners's latest lobbying report covers Q3 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

National Cardiovascular Partners

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

National Cardiovascular Partners lobbying by quarter
National Cardiovascular Partners lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$0 · 8 reports
  • Medicare and Medicaid$0 · 8 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)8 reports
  • Health & Human Services, Dept of (HHS)8 reports
  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE8 reports

Firms it paid

Firm
Liberty Partners Group$08 quarters

Former officials lobbying for it

Former position
JASON S MCKITRICKAnalyst, House Budget; LA Rep. John KasichQ3 2024

Lobbying reports

Filed by
24/10/19for Q3 2024Liberty Partners GroupUnder $5,000
24/07/19for Q2 2024Liberty Partners GroupUnder $5,000
24/04/19for Q1 2024Liberty Partners GroupUnder $5,000
24/01/19for Q4 2023Liberty Partners GroupUnder $5,000
23/10/19for Q3 2023Liberty Partners GroupUnder $5,000
23/07/20for Q2 2023Liberty Partners GroupUnder $5,000
23/04/20for Q1 2023Liberty Partners GroupUnder $5,000
23/01/20for Q4 2022Liberty Partners GroupUnder $5,000